Search results
Results from the WOW.Com Content Network
The U.S. Federal Trade Commission (FTC) has allowed Amgen to continue its $27.8 billion acquisition of Horizon Therapeutics, while preventing the drugmaker from using anticompetitive tactics to ...
(Reuters) -The U.S. Federal Trade Commission (FTC) has suspended its challenge of Amgen's $27.8 billion purchase of Horizon Therapeutics, allowing the FTC to consider whether the agency should ...
Under the settlement terms with the FTC following its lawsuit to block the deal, Amgen is prevented from using anti-competitive tactics to extend the market dominance of Horizon's fast-growing ...
Horizon believed it could reach $1 billion peak sales in the US alone. In February 2021, the business announced it would acquire Viela Bio Inc for around $3 billion ($53 per share). [15] [16] In December 2022, the company announced it would be acquired by Amgen for $27.8 billion ($116.50 in cash for each Horizon share, a 20% premium). [17]
Amgen added Uplizna via a $27.8 billion acquisition of Horizon Therapeutics and recorded sales of $80 million in the first quarter of 2024. The trial met its primary endpoint, showing a ...
For premium support please call: 800-290-4726 more ways to reach us
AMGen corporate logo, 1983 Argentine president Mauricio Macri meets with heads of Amgen, in 2018. Amgen was established in Thousand Oaks in 1980, as Applied Molecular Genetics. [6] [7] Amgen was backed by a small group of venture capitalists, and its early focus was on recombinant DNA technology and recombinant human insulin. [8]
Excluding Horizon's drugs, Amgen said product sales grew 5%. Investors are focused on progress with the weight-loss drug MariTide. The company said it expects to have initial data from a mid-stage ...